Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

Presentation TCT 2013

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

Case Presentation: BTK Intervention is a Different Animal: Implications for DCB development

Presenter: Jihad Mustapha

October 31, 2013

Presentation TCT 2013

Synthesis of the Available Drug-Coated Balloon Clinical Data in BTK Intervention

Presenter: Dierk Scheinert

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

Presentation TCT 2012

Drug Eluting Balloon For Below The Knee Angioplasty Evaluation: The DEBATE BTK Study

Presenter: Francesco Liistro, Paolo Angioli, Simone Grotti, Filippo Turini, Kenneth Ducci, Giorgio Ventoruzzo, Lucia Ricci, Giovanni Falsini, Guido Bellandi, Leonardo Bolognese

January 03, 2012

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

What’s Going to Be Hot at TCT 2025

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Case Presentation: BTK Intervention is a Different Animal: Implications for DCB development

Synthesis of the Available Drug-Coated Balloon Clinical Data in BTK Intervention

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Drug Eluting Balloon For Below The Knee Angioplasty Evaluation: The DEBATE BTK Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content